VC Catalog · venture ecosystem research library
VC Catalog home Beta

VC firm

Sofinnova Investments

Kingmaker TierBased on the data VC Catalog holds.

Kingmaker Tier: 98 out of 100

Also known as Soffinova, Soffinova Partners, Sofinnova, Sofinnova BioEquities, Sofinnova BioEquities Enhanced, Sofinnova Synergy

  • Biotech & therapeutics
  • Care delivery & digital health
  • Health IT
  • Medical devices & diagnostics
  • Mental health & wellness
  • Women's & family health
  • US
  • Europe
  • VC
  • B2B
Investor type
VC
Investing status
Activeas of 2026-09-17Source (opens in a new tab)
Headquarters
Menlo Park, CA, United States
Founded
1976
Assets under management
$4.6BStated by firm, as of 2026-09-17Source (opens in a new tab)
Latest fund size
$527MSEC amount sold, as of 2026-06-22Source (opens in a new tab)
Funds
10
Legal name
SOFINNOVA INVESTMENTS, INC.
Claim, correct or request removal

Record updated 27 September 2026

About

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

Investment approach

Thesis
Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital.Source (opens in a new tab)
Takes board seats
Yes
Board policy
we strive to be collaborative, meaningful board members, and excellent partners at every level.
Investing status notes
We actively partner with entrepreneurs in both the U.S. and Europe who want to rewrite the quality of healthcare today for a better life tomorrow.

Funds

Sofinnova Venture Partners XII, L.P.
$527MVintage 2024, Closed, SEC amount sold
Sofinnova BioEquities Enhanced Offshore Fund Ltd.
$226MVintage 2022, Open-ended, SEC amount sold
Sofinnova BioEquities Enhanced Master Fund, LP
$41.5MVintage 2022, Open-ended, SEC amount sold
Sofinnova Venture Partners XI, L.P.
$500MVintage 2021, Closed, SEC amount sold
Sofinnova Synergy Master Fund, LP
$4.9MVintage 2021, Open-ended, SEC amount sold
Sofinnova BioEquities, LP
$377MVintage 2017, Open-ended, SEC amount sold
Sofinnova Venture Partners X, L.P.
$596MVintage 2016, Main fund, Closed, SEC amount sold
Sofinnova Venture Partners VIII, L.P.
$440MVintage 2011, Main fund, Closed, SEC amount sold
Sofinnova Venture Partners IX, L.P.
Main fund
SOFINNOVA VENTURE PARTNERS XII, L.P.
Main fund

SEC registration

Registered adviser
SOFINNOVA INVESTMENTS, INC.
SEC file number
801-110134
Registration
SEC registered
Regulatory AUM
$5.4Bas of 2026-03-27
Private funds reported
7
Principal office
MENLO PARK, CA, United States

Locations

Office
Boston, MA, United States
Office
Menlo Park, CA, United States
Office
New York, NY, United States
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy